TRANSLATING EARLY RESEARCH INTO PROMISING NEW ATMPS FOR PATIENTS THROUGH PUBLIC-PRIVATE PARTNERSHIPS

This session will shine the spotlight on European public-private partnership initiatives for ATMPs and why they can play an important role in accelerating patient access to innovative therapies.
Moderator:
Petter Björquist, Ph.D., CEO, VERIGRAFT
Speakers:
Elsa Abranches, Ph.D., Senior Director, Head of Cell Therapy Bioprocess Development and Manufacturing, BioPharmaceuticals R&D, AstraZeneca
Elias Uhlin, Ph.D., Project Manager, Cell and Gene Therapy, Pre- GMP Facility, Lund University